Although markers of insulin resistance (ΔTG/HDL-C ratio, ΔTyG index) as well as liver stiffness and steatosis indices (CAP) showed no significant change after the intervention, plasma FGF21 levels decreased despite stable BMI. This evidence concerns the gene FGF21 and Insulin resistance.